HQH (abrdn Healthcare Investors) PE Ratio without NRI: 4.92 (As of Jul. 05, 2026) — 34% Below Median


HQH abrdn Healthcare Investors HQH
40 GF Score
Price $22.00
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors PE Ratio without NRI?

abrdn Healthcare Investors HQH +1.24% 40 PE Ratio without NRI is 4.92 as of Jul. 05, 2026, which is 34% below its 10-year median of 7.51. GuruFocus rates HQH with a GF Score™ of 40/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,199 Asset Management companies, abrdn Healthcare Investors ranks better than 84.24% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-05), abrdn Healthcare Investors's share price is $22.00. abrdn Healthcare Investors's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47. Therefore, abrdn Healthcare Investors's PE Ratio without NRI for today is 4.92.

During the past 9 years, abrdn Healthcare Investors's highest PE Ratio without NRI was 17.66. The lowest was 3.63. And the median was 7.51.

abrdn Healthcare Investors's EPS without NRI for the six months ended in Mar. 2026 was $1.38. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47.

As of today (2026-07-05), abrdn Healthcare Investors's share price is $22.00. abrdn Healthcare Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47. Therefore, abrdn Healthcare Investors's PE Ratio (TTM) for today is 4.92.

Warning Sign:

abrdn Healthcare Investors stock PE Ratio (=13.66) is close to 1-year high of 13.66.

During the past years, abrdn Healthcare Investors's highest PE Ratio (TTM) was 17.66. The lowest was 3.63. And the median was 7.51.

abrdn Healthcare Investors's EPS (Diluted) for the six months ended in Mar. 2026 was $1.38. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47.

abrdn Healthcare Investors's EPS (Basic) for the six months ended in Mar. 2026 was $1.38. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47.


abrdn Healthcare Investors  (NYSE:HQH) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


abrdn Healthcare Investors PE Ratio without NRI Related Terms


abrdn Healthcare Investors PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for abrdn Healthcare Investors's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Healthcare Investors PE Ratio without NRI Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only 7.33 At Loss 14.27 5.27 11.47

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 5.27 At Loss 11.47 At Loss

HQH vs DSL, NMZ, JFR: PE Ratio without NRI Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors PE Ratio without NRI vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's PE Ratio without NRI falls into.


HQH
40GF Score
abrdn Healthcare Investors HQH
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

abrdn Healthcare Investors PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

abrdn Healthcare Investors's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=22.00/4.470
=4.92

abrdn Healthcare Investors's Share Price of today is $22.00.
For company reported semi-annually, abrdn Healthcare Investors's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.47.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 4.92 mean?
abrdn Healthcare Investors (HQH) has a PE Ratio without NRI of 4.92 as of Jul. 05, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on abrdn Healthcare Investors and its competitors. This is 34% below median its historical median of 7.51. Over the past decade, abrdn Healthcare Investors' PE Ratio without NRI has ranged from 3.63 to 17.66. According to the industry distribution chart, abrdn Healthcare Investors ranks #189 out of 1199 companies in the Asset Management industry, placing it in the top 15.8%.
Is abrdn Healthcare Investors' PE Ratio without NRI too high?
abrdn Healthcare Investors' current PE Ratio without NRI of 4.92 is 34% below median its 10-year median of 7.51. Over the past 10 years, this metric has ranged from a low of 3.63 to a high of 17.66. The Asset Management industry median PE Ratio without NRI is 11.69. abrdn Healthcare Investors' value of 4.92 is 57.9% below this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #189 out of 1199 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' PE Ratio without NRI compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #189 out of 1199 companies for PE Ratio without NRI. This places abrdn Healthcare Investors in the top 16% of its industry — outperforming the majority of peers. The industry median PE Ratio without NRI is 11.69. abrdn Healthcare Investors' value of 4.92 is 57.9% below this benchmark. Historically, abrdn Healthcare Investors' own PE Ratio without NRI has ranged from 3.63 to 17.66 over the past decade. While the company's 10-year median is 7.51 vs. the industry median of 11.69, abrdn Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for an Asset Management company?
The median PE Ratio without NRI among Asset Management companies is 11.69, based on 1,199 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current PE Ratio without NRI of 4.92 is 57.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median PE Ratio without NRI is 11.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current PE Ratio without NRI is 4.92, which is 34% below median its own 10-year median of 7.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $22.00 — trading 56.2% below its estimated fair value. The current PE Ratio without NRI is 4.92, which is 34% below median its 10-year median of 7.51 and 57.9% below the Asset Management industry median of 11.69. abrdn Healthcare Investors' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current PE Ratio without NRI is 4.92 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $22.00 is trading 56.2% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • PE Ratio without NRI: 4.92 (34% below median its 10-year median of 7.51)
  • GF Value™: $50.26 vs. price of $22.00 (56.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs
  • Industry Position: 57.9% below the Asset Management median (#189 of 1199)

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
40GF Score

Get the complete analysis for HQH

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price
$50.26
GF Value